Xenetic Biosciences Files 8-K
Ticker: XBIO · Form: 8-K · Filed: May 14, 2025 · CIK: 1534525
| Field | Detail |
|---|---|
| Company | Xenetic Biosciences, Inc. (XBIO) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, filing
TL;DR
Xenetic Biosciences filed an 8-K on 5/14/25 with updated HQ info in Framingham, MA.
AI Summary
On May 14, 2025, Xenetic Biosciences, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 945 Concord Street, Framingham, Massachusetts, 01701. The company was incorporated in Nevada and its fiscal year ends on December 31st.
Why It Matters
This 8-K filing provides updated corporate information and addresses for Xenetic Biosciences, Inc., which is important for investors and stakeholders to have the most current contact and location details.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not contain significant financial or operational news that would inherently increase risk.
Key Players & Entities
- Xenetic Biosciences, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of earliest event reported
- 945 Concord Street, Framingham, Massachusetts 01701 (location) — Principal executive offices
- Nevada (jurisdiction) — State of incorporation
- 001-37937 (identifier) — Commission File Number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 14, 2025.
Where are Xenetic Biosciences, Inc.'s principal executive offices located?
The principal executive offices are located at 945 Concord Street, Framingham, Massachusetts 01701.
In which state was Xenetic Biosciences, Inc. incorporated?
Xenetic Biosciences, Inc. was incorporated in Nevada.
What is the Commission File Number for Xenetic Biosciences, Inc.?
The Commission File Number is 001-37937.
When does Xenetic Biosciences, Inc.'s fiscal year end?
Xenetic Biosciences, Inc.'s fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Xenetic Biosciences, Inc. (XBIO).